1564256-53-6Relevant articles and documents
Novel 2,4-diarylaminopyrimidine analogues (DAAPalogues) showing potent c-Met/ALK multikinase inhibitory activities
Liu, Zhiqing,Ai, Jing,Peng, Xia,Song, Zilan,Wu, Kui,Zhang, Jing,Yao, Qizheng,Chen, Yi,Ji, Yinchun,Yang, Yanhong,Geng, Meiyu,Zhang, Ao
, p. 304 - 308 (2014/05/06)
By repurposing a typical dopamine D1/D5 receptor agonist motif, C1-substituted-N3-benzazepine or benzazecine, into the classical RTK inhibitor 2,4-diaminopyrimidine skeleton, a series of new 2,4-diarylaminopyrimidine analogues (DAAPa